Roidace 25 / 50 / 75 / 100 / 200 μg Tablet.
PDF Leaflet Revision Date: 20 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Untreated hypothyroidism.
Dosage (summary)
Adults: Initially 50-100 u03bcg daily, adjust by 50 u03bcg every 3-4 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Thyroxine dosage may need adjustment during pregnancy; monitor TSH levels.
Key Drug Interactions
- Warfarin
- Phenytoin
- Carbamazepine
- Digoxin
- Cholestyramine
Contraindications
- Hypersensitivity
- Untreated hyperthyroidism
- Untreated adrenal insufficiency
Common side effects
- Hyperthyroidism
- Angina pectoris
- Palpitations
- Nausea
- Hair loss
Counselling Points
- Take before breakfast
- Do not double doses
- Monitor for side effects
Serious warnings
- Narrow therapeutic index
- Thyroid storm risk
- Monitor thyroid function regularly
Important Disclaimer
The Roidace 25 / 50 / 75 / 100 / 200 μg Tablet. professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
